U.S. Physical Therapy Stock Forecast, Price & News

U.S. Physical Therapy (NYSE:USPH) Frequently Asked Questions

Is U.S. Physical Therapy a buy right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for U.S. Physical Therapy in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" U.S. Physical Therapy stock.
View analyst ratings for U.S. Physical Therapy or view top-rated stocks.

How has U.S. Physical Therapy's stock price been impacted by COVID-19 (Coronavirus)?

U.S. Physical Therapy's stock was trading at $93.22 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, USPH shares have decreased by 3.2% and is now trading at $90.25.
View which stocks have been most impacted by COVID-19.

When is U.S. Physical Therapy's next earnings date?

U.S. Physical Therapy is scheduled to release its next quarterly earnings announcement on Thursday, February 24th 2022.
View our earnings forecast for U.S. Physical Therapy.

How were U.S. Physical Therapy's earnings last quarter?

U.S. Physical Therapy, Inc. (NYSE:USPH) issued its quarterly earnings data on Thursday, November, 4th. The company reported $0.85 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.78 by $0.07. The firm had revenue of $125.90 million for the quarter, compared to analyst estimates of $124.67 million. U.S. Physical Therapy had a net margin of 6.64% and a trailing twelve-month return on equity of 16.63%. The business's revenue for the quarter was up 15.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.86 earnings per share.
View U.S. Physical Therapy's earnings history.

How often does U.S. Physical Therapy pay dividends? What is the dividend yield for U.S. Physical Therapy?

U.S. Physical Therapy declared a quarterly dividend on Tuesday, November 2nd. Shareholders of record on Monday, November 15th will be given a dividend of $0.38 per share on Friday, December 10th. This represents a $1.52 annualized dividend and a dividend yield of 1.68%. The ex-dividend date of this dividend is Friday, November 12th.
View U.S. Physical Therapy's dividend history.

Is U.S. Physical Therapy a good dividend stock?

U.S. Physical Therapy pays an annual dividend of $1.52 per share and currently has a dividend yield of 1.66%. U.S. Physical Therapy has been increasing its dividend for 10 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of U.S. Physical Therapy is 64.14%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, U.S. Physical Therapy will have a dividend payout ratio of 45.65% next year. This indicates that U.S. Physical Therapy will be able to sustain or increase its dividend.
View U.S. Physical Therapy's dividend history.

What price target have analysts set for USPH?

4 analysts have issued 12-month price targets for U.S. Physical Therapy's stock. Their forecasts range from $120.00 to $139.00. On average, they anticipate U.S. Physical Therapy's stock price to reach $131.33 in the next year. This suggests a possible upside of 45.5% from the stock's current price.
View analysts' price targets for U.S. Physical Therapy or view top-rated stocks among Wall Street analysts.

Who are U.S. Physical Therapy's key executives?

U.S. Physical Therapy's management team includes the following people:

• Christopher J. Reading, President, Chief Executive Officer & Director (LinkedIn Profile)
• Graham Reeve, Chief Operating Officer-East Region (LinkedIn Profile)
• Carey P. Hendrickson, Chief Financial Officer
• Chadd Pence, Vice President-Information Systems
• Jayne Fleck Pool, Chief Compliance Officer & VP-Clinical Services

What is Chris Reading's approval rating as U.S. Physical Therapy's CEO?

38 employees have rated U.S. Physical Therapy CEO Chris Reading on Glassdoor.com. Chris Reading has an approval rating of 49% among U.S. Physical Therapy's employees. This puts Chris Reading in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of U.S. Physical Therapy's key competitors?

Some companies that are related to U.S. Physical Therapy include HCA Healthcare (HCA), Alcon (ALC), Universal Health Services (UHS), Tenet Healthcare (THC), Encompass Health (EHC), Acadia Healthcare (ACHC), The Ensign Group (ENSG), Petco Health and Wellness (WOOF), Select Medical (SEM), Community Health Systems (CYH), National HealthCare (NHC), Brookdale Senior Living (BKD) and Five Star Senior Living (FVE).
View all of USPH's competitors.

What other stocks do shareholders of U.S. Physical Therapy own?

Based on aggregate information from My MarketBeat watchlists, some companies that other U.S. Physical Therapy investors own include Pfizer (PFE), NVIDIA (NVDA), AbbVie (ABBV), CVS Health (CVS), Gilead Sciences (GILD), International Business Machines (IBM), Illumina (ILMN), Johnson & Johnson (JNJ), Lowe's Companies (LOW) and Marathon Petroleum (MPC).

What is U.S. Physical Therapy's stock symbol?

U.S. Physical Therapy trades on the New York Stock Exchange (NYSE) under the ticker symbol "USPH."

Who are U.S. Physical Therapy's major shareholders?

U.S. Physical Therapy's stock is owned by a variety of retail and institutional investors. Top institutional investors include Copeland Capital Management LLC (3.22%), Riverbridge Partners LLC (2.95%), Fenimore Asset Management Inc. (0.82%), Scout Investments Inc. (0.70%), State of Alaska Department of Revenue (0.07%) and Precision Wealth Strategies LLC (0.03%). Company insiders that own U.S. Physical Therapy stock include Bernard A Harris Jr, Bernard A Harris, Jr, Christopher J Reading, Christopher J Reading, Edward L Kuntz, Glenn Mcdowell, Graham D Reeve, Graham D Reeve, Harry S Chapman, Kathleen A Gilmartin, Lawrance W Mcafee, Mark J Brookner and Regg E Swanson.
View institutional ownership trends for U.S. Physical Therapy.

Which major investors are selling U.S. Physical Therapy stock?

USPH stock was sold by a variety of institutional investors in the last quarter, including Scout Investments Inc., and State of Alaska Department of Revenue. Company insiders that have sold U.S. Physical Therapy company stock in the last year include Christopher J Reading, Edward L Kuntz, Glenn Mcdowell, Graham D Reeve, Harry S Chapman, Lawrance W Mcafee, and Mark J Brookner.
View insider buying and selling activity for U.S. Physical Therapy or view top insider-selling stocks.

Which major investors are buying U.S. Physical Therapy stock?

USPH stock was acquired by a variety of institutional investors in the last quarter, including Copeland Capital Management LLC, Riverbridge Partners LLC, Fenimore Asset Management Inc., and Precision Wealth Strategies LLC. Company insiders that have bought U.S. Physical Therapy stock in the last two years include Harry S Chapman, Kathleen A Gilmartin, and Regg E Swanson.
View insider buying and selling activity for U.S. Physical Therapy or or view top insider-buying stocks.

How do I buy shares of U.S. Physical Therapy?

Shares of USPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is U.S. Physical Therapy's stock price today?

One share of USPH stock can currently be purchased for approximately $90.25.

How much money does U.S. Physical Therapy make?

U.S. Physical Therapy has a market capitalization of $1.17 billion and generates $422.97 million in revenue each year. The company earns $35.19 million in net income (profit) each year or $2.37 on an earnings per share basis.

How many employees does U.S. Physical Therapy have?

U.S. Physical Therapy employs 4,630 workers across the globe.

What is U.S. Physical Therapy's official website?

The official website for U.S. Physical Therapy is www.usph.com.

Where are U.S. Physical Therapy's headquarters?

U.S. Physical Therapy is headquartered at 1300 WEST SAM HOUSTON PARKWAY SUITE 300, HOUSTON TX, 77042.

How can I contact U.S. Physical Therapy?

U.S. Physical Therapy's mailing address is 1300 WEST SAM HOUSTON PARKWAY SUITE 300, HOUSTON TX, 77042. The company can be reached via phone at (713) 297-7000, via email at [email protected], or via fax at 713-297-7090.